Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 35

1.

HIC1 (hypermethylated in cancer 1) SUMOylation is dispensable for DNA repair but is essential for the apoptotic DNA damage response (DDR) to irreparable DNA double-strand breaks (DSBs).

Paget S, Dubuissez M, Dehennaut V, Nassour J, Harmon BT, Spruyt N, Loison I, Abbadie C, Rood BR, Leprince D.

Oncotarget. 2017 Jan 10;8(2):2916-2935. doi: 10.18632/oncotarget.13807.

2.

Protein Kinase C-Mediated Phosphorylation of BCL11B at Serine 2 Negatively Regulates Its Interaction with NuRD Complexes during CD4+ T-Cell Activation.

Dubuissez M, Loison I, Paget S, Vorng H, Ait-Yahia S, Rohr O, Tsicopoulos A, Leprince D.

Mol Cell Biol. 2016 Jun 15;36(13):1881-98. doi: 10.1128/MCB.00062-16. Print 2016 Jul 1.

3.

HIC1 Tumor Suppressor Loss Potentiates TLR2/NF-κB Signaling and Promotes Tissue Damage-Associated Tumorigenesis.

Janeckova L, Pospichalova V, Fafilek B, Vojtechova M, Tureckova J, Dobes J, Dubuissez M, Leprince D, Baloghova N, Horazna M, Hlavata A, Stancikova J, Sloncova E, Galuskova K, Strnad H, Korinek V.

Mol Cancer Res. 2015 Jul;13(7):1139-48. doi: 10.1158/1541-7786.MCR-15-0033. Epub 2015 May 1.

4.

Retraction for Zhang et al., Metabolic regulation of SIRT1 transcription via a HIC1:CtBP corepressor complex.

Zhang Q, Wang SY, Fleuriel C, Dominique L, Rocheleau JV, Piston DW, Goodman RH.

Proc Natl Acad Sci U S A. 2015 Feb 17;112(7):E819. doi: 10.1073/pnas.1501052112. Epub 2015 Feb 2. No abstract available.

5.

O-GlcNAcylation, an Epigenetic Mark. Focus on the Histone Code, TET Family Proteins, and Polycomb Group Proteins.

Dehennaut V, Leprince D, Lefebvre T.

Front Endocrinol (Lausanne). 2014 Sep 26;5:155. doi: 10.3389/fendo.2014.00155. eCollection 2014. Review.

6.

The Reelin receptors ApoER2 and VLDLR are direct target genes of HIC1 (Hypermethylated In Cancer 1).

Dubuissez M, Faiderbe P, Pinte S, Dehennaut V, Rood BR, Leprince D.

Biochem Biophys Res Commun. 2013 Oct 25;440(3):424-30. doi: 10.1016/j.bbrc.2013.09.091. Epub 2013 Sep 25.

PMID:
24076391
7.

HIC1 interacts with and modulates the activity of STAT3.

Lin YM, Wang CM, Jeng JC, Leprince D, Shih HM.

Cell Cycle. 2013 Jul 15;12(14):2266-76. doi: 10.4161/cc.25365.

8.

A SUMOylation-dependent pathway regulates SIRT1 transcription and lung cancer metastasis.

Sun L, Li H, Chen J, Dehennaut V, Zhao Y, Yang Y, Iwasaki Y, Kahn-Perles B, Leprince D, Chen Q, Shen A, Xu Y.

J Natl Cancer Inst. 2013 Jun 19;105(12):887-98. doi: 10.1093/jnci/djt118. Epub 2013 May 23.

PMID:
23704280
9.

Deciphering HIC1 control pathways to reveal new avenues in cancer therapeutics.

Rood BR, Leprince D.

Expert Opin Ther Targets. 2013 Jul;17(7):811-27. doi: 10.1517/14728222.2013.788152. Epub 2013 Apr 9. Review.

10.

DNA double-strand breaks lead to activation of hypermethylated in cancer 1 (HIC1) by SUMOylation to regulate DNA repair.

Dehennaut V, Loison I, Dubuissez M, Nassour J, Abbadie C, Leprince D.

J Biol Chem. 2013 Apr 12;288(15):10254-64. doi: 10.1074/jbc.M112.421610. Epub 2013 Feb 15.

11.

Identification of p21 (CIP1/WAF1) as a direct target gene of HIC1 (Hypermethylated In Cancer 1).

Dehennaut V, Loison I, Boulay G, Van Rechem C, Leprince D.

Biochem Biophys Res Commun. 2013 Jan 4;430(1):49-53. doi: 10.1016/j.bbrc.2012.11.045. Epub 2012 Nov 22.

PMID:
23178572
12.

Molecular dissection of the interaction between HIC1 and SIRT1.

Dehennaut V, Loison I, Pinte S, Leprince D.

Biochem Biophys Res Commun. 2012 May 4;421(2):384-8. doi: 10.1016/j.bbrc.2012.04.026. Epub 2012 Apr 9.

PMID:
22510409
13.

The transcription factor encyclopedia.

Yusuf D, Butland SL, Swanson MI, Bolotin E, Ticoll A, Cheung WA, Zhang XY, Dickman CT, Fulton DL, Lim JS, Schnabl JM, Ramos OH, Vasseur-Cognet M, de Leeuw CN, Simpson EM, Ryffel GU, Lam EW, Kist R, Wilson MS, Marco-Ferreres R, Brosens JJ, Beccari LL, Bovolenta P, Benayoun BA, Monteiro LJ, Schwenen HD, Grontved L, Wederell E, Mandrup S, Veitia RA, Chakravarthy H, Hoodless PA, Mancarelli MM, Torbett BE, Banham AH, Reddy SP, Cullum RL, Liedtke M, Tschan MP, Vaz M, Rizzino A, Zannini M, Frietze S, Farnham PJ, Eijkelenboom A, Brown PJ, Laperrière D, Leprince D, de Cristofaro T, Prince KL, Putker M, del Peso L, Camenisch G, Wenger RH, Mikula M, Rozendaal M, Mader S, Ostrowski J, Rhodes SJ, Van Rechem C, Boulay G, Olechnowicz SW, Breslin MB, Lan MS, Nanan KK, Wegner M, Hou J, Mullen RD, Colvin SC, Noy PJ, Webb CF, Witek ME, Ferrell S, Daniel JM, Park J, Waldman SA, Peet DJ, Taggart M, Jayaraman PS, Karrich JJ, Blom B, Vesuna F, O'Geen H, Sun Y, Gronostajski RM, Woodcroft MW, Hough MR, Chen E, Europe-Finner GN, Karolczak-Bayatti M, Bailey J, Hankinson O, Raman V, LeBrun DP, Biswal S, Harvey CJ, DeBruyne JP, Hogenesch JB, Hevner RF, Héligon C, Luo XM, Blank MC, Millen KJ, Sharlin DS, Forrest D, Dahlman-Wright K, Zhao C, Mishima Y, Sinha S, Chakrabarti R, Portales-Casamar E, Sladek FM, Bradley PH, Wasserman WW.

Genome Biol. 2012;13(3):R24. doi: 10.1186/gb-2012-13-3-r24.

14.

Hypermethylated in cancer 1 (HIC1) recruits polycomb repressive complex 2 (PRC2) to a subset of its target genes through interaction with human polycomb-like (hPCL) proteins.

Boulay G, Dubuissez M, Van Rechem C, Forget A, Helin K, Ayrault O, Leprince D.

J Biol Chem. 2012 Mar 23;287(13):10509-24. doi: 10.1074/jbc.M111.320234. Epub 2012 Feb 7.

15.

Loss of Hypermethylated in Cancer 1 (HIC1) in breast cancer cells contributes to stress-induced migration and invasion through β-2 adrenergic receptor (ADRB2) misregulation.

Boulay G, Malaquin N, Loison I, Foveau B, Van Rechem C, Rood BR, Pourtier A, Leprince D.

J Biol Chem. 2012 Feb 17;287(8):5379-89. doi: 10.1074/jbc.M111.304287. Epub 2011 Dec 22.

16.

The receptor tyrosine kinase EphA2 is a direct target gene of hypermethylated in cancer 1 (HIC1).

Foveau B, Boulay G, Pinte S, Van Rechem C, Rood BR, Leprince D.

J Biol Chem. 2012 Feb 17;287(8):5366-78. doi: 10.1074/jbc.M111.329466. Epub 2011 Dec 19.

17.

Generation of two modified mouse alleles of the Hic1 tumor suppressor gene.

Pospichalova V, Tureckova J, Fafilek B, Vojtechova M, Krausova M, Lukas J, Sloncova E, Takacova S, Divoky V, Leprince D, Plachy J, Korinek V.

Genesis. 2011 Mar;49(3):142-51. doi: 10.1002/dvg.20719.

PMID:
21309068
18.

Functional characterization of human Polycomb-like 3 isoforms identifies them as components of distinct EZH2 protein complexes.

Boulay G, Rosnoblet C, Guérardel C, Angrand PO, Leprince D.

Biochem J. 2011 Mar 1;434(2):333-42. doi: 10.1042/BJ20100944.

PMID:
21143197
19.

Arginine 469 is a pivotal residue for the Hsc70-GlcNAc-binding property.

Guinez C, Mir AM, Martin N, Leprince D, Michalski JC, Vergoten G, Lefebvre T.

Biochem Biophys Res Commun. 2010 Oct 1;400(4):537-42. doi: 10.1016/j.bbrc.2010.08.089. Epub 2010 Sep 17.

PMID:
20804732
20.

Differential regulation of HIC1 target genes by CtBP and NuRD, via an acetylation/SUMOylation switch, in quiescent versus proliferating cells.

Van Rechem C, Boulay G, Pinte S, Stankovic-Valentin N, Guérardel C, Leprince D.

Mol Cell Biol. 2010 Aug;30(16):4045-59. doi: 10.1128/MCB.00582-09. Epub 2010 Jun 14.

Supplemental Content

Loading ...
Support Center